Current Research Studies
An open-label, single-arm study to evaluate pharmacokinetics and safety of subcutaneous sonelokimab in adolescents with moderate to severe hidradenitis suppurativa
Sonelokimab for HS (MoonLake)
What is the goal of the study?
M1095-HS-304 is a Phase 3, single-arm study to evaluate the pharmacokinetics and safety of sonelokimab in adolescents with moderate to severe hidradenitis suppurativa (HS).
Who can participate in the study?
Please contact the study team listed below to learn more.